Safety & quality.
Most peptide sites are weakest on safety. This is a framework for thinking about risk honestly, not personalized medical advice.
- Risk comes in four kinds: known, theoretical, unknown, and quality. For most research peptides, unknown is the biggest.
- A high purity number is not safety. It says nothing about sterility, endotoxin, or whether the compound was ever studied in humans.
- Some people carry much higher risk, which is a reason to involve a professional, not to self-experiment.
Four kinds of risk.
Lumping all risk into one “side effects” line hides the most important fact: how much is actually known. Separating it makes the gaps visible.
Adverse effects documented in human studies, drug labels, or post-market reports. The smallest, best-understood category.
Risks inferred from a compound's mechanism but not yet observed in people: plausible, but unconfirmed.
Effects that simply haven't been studied, especially long-term. For most research peptides this is the largest category.
Contamination, endotoxin, degradation, mislabeling, and sterility failures from non-pharmaceutical sources.
A Certificate of Analysis answers one narrow question.
A COA reports chemistry: identity and purity, usually by HPLC and mass spectrometry. That is useful, but it is a single slice of safety. Knowing what it does and does not cover is the whole game.
- ✓The molecule's identity matches the label
- ✓Purity above a stated threshold (e.g. by HPLC)
- ✓Molecular weight by mass spec
- ✓Sometimes: a batch-specific endotoxin or sterility result
- ✕Sterility (unless that specific test is listed)
- ✕Freedom from bacterial endotoxin (same caveat)
- ✕Correct storage, handling, or shipping
- ✕Any clinical safety or efficacy in humans
Reading a COA without fooling yourself.
Match the batch
The COA's batch / lot number must match the vial in hand. A generic or mismatched COA proves nothing about your product.
Check who ran it
An independent third-party lab is stronger than an in-house sheet. No lab named is a red flag.
Read which tests were actually run
Identity and purity are common; sterility and endotoxin often are not. Absent tests are absent results, so don't assume a pass.
Separate purity from safety
Treat the purity figure as a chemistry fact, not a health verdict. The other three risk kinds still apply.
Risk is not the same for everyone.
Any of these can change the risk picture substantially, sometimes turning a “probably minor” into a serious one. They are reasons to involve a qualified professional, not a basis for self-administration:
The contamination nobody accounts for.
Sterility gets discussed. Endotoxins almost never do, and they are the more instructive risk because of how thoroughly they defeat the intuitions people rely on.
Endotoxins are fragments of gram-negative bacterial cell walls, specifically lipopolysaccharide. They are not organisms, so killing bacteria does not remove them. They pass through the 0.22 micron filters used to sterilise solutions, because they are far smaller than the pore size. They are heat stable enough to survive conditions that destroy the bacteria that produced them. They are colourless and odourless, so a contaminated vial is visually identical to a clean one. And they are not detected by the HPLC purity testing that appears on a Certificate of Analysis, because they are a different class of molecule entirely.
Counterfeits and substitution.
An unregulated supply chain has no lot release testing, no manufacturing inspection, and no recall mechanism. Those three absences are what make substitution economically rational rather than merely possible, and the market has no self-correcting feedback loop when it happens.
The verification most people rely on is weaker than it appears. Mass spectrometry confirms a molecular weight, which means an analogue of similar mass can satisfy the check. Underfilling a vial is invisible without quantitative analysis. Net peptide content, the fraction of the powder that is actually peptide rather than counterions and residual water, is routinely omitted from documentation and can be a substantial share of the mass. A vial that is genuinely the labelled compound can still contain far less of it than the label implies.
This is also why price is a signal worth reading. Peptide synthesis has real costs that do not vary much between honest manufacturers, so pricing far below the rest of the market is usually a statement about what is in the vial rather than about efficiency. See how to vet a supplier for what the documentation can and cannot establish.